-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
In-vitro Diagnostics Instruments Market to Record a CAGR of 7.95% | Technavio
In-vitro Diagnostics Instruments Market to Record a CAGR of 7.95% | Technavio
NEW YORK, Nov. 25, 2021 /PRNewswire/ -- The in-vitro diagnostics instruments market is expected to grow by USD 23.00 bn from 2020 to 2025, according to Technavio. The report offers an updated analysis of the present market scenario, the latest trends and drivers, and the overall market environment.
Fetch Free Sample Report to explore growth opportunities in the in-vitro diagnostics instruments market
Top 3 In-vitro Diagnostics Instruments Market Players
- Abbott Laboratories- The company offers in-vitro diagnostics instruments, namely Sapphire, Ruby, Emerald 22AL, and others.
- Becton Dickinson and Co.- The company offers in-vitro diagnostics instruments for mycobacteria testing and identification and susceptibility systems.
- Bio Rad Laboratories Inc.- The company offers in-vitro diagnostics instruments to screen microbial presence, grow and identify organisms, and test for antibiotic susceptibility.
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!
In-vitro Diagnostics Instruments Market 2021-2025: Segmentation
- Product
- Immunochemistry
- Clinical Microbiology
- Molecular Diagnostics
- Others
- End-user
- Hospitals And Diagnostic Laboratories
- Academic And Research Institutes
- Home Care
- Geography
- North America
- Europe
- Asia
- ROW
The in-vitro diagnostics instruments market is driven by the growing geriatric population, demand for personalized medicine, and product launches.
Download Our Free Sample for more information about market segmentation as well as the latest trends, drivers, and challenges
Reports that might interest you:
- Surgical Instruments Market: The surgical instruments market has been segmented by product (surgical sutures and stapling devices, handheld surgical devices, and electrosurgical devices) and geography (North America, Asia, Europe, and ROW). Download Free Sample Report
- Ventricular Assist Devices Market: The ventricular assist devices market has been segmented by product (left and right ventricular assist devices and bi-ventricular assist devices) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
In-vitro Diagnostics Instruments Market Scope | |
Report Coverage | Details |
Page number | 120 |
Base year | 2020 |
Forecast period | 2021-2025 |
Growth momentum & CAGR | Accelerate at a CAGR of 7.95% |
Market growth 2021-2025 | USD 23.00 billion |
Market structure | Fragmented |
YoY growth (%) | 6.23 |
Regional analysis | North America, Europe, Asia, and ROW |
Performing market contribution | North America at 35% |
Key consumer countries | US, China, Germany, Canada, and UK |
Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
Companies profiled | Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., HORIBA Ltd., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
Market Dynamics | Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
NEW YORK, Nov. 25, 2021 /PRNewswire/ -- The in-vitro diagnostics instruments market is expected to grow by USD 23.00 bn from 2020 to 2025, according to Technavio. The report offers an updated analysis of the present market scenario, the latest trends and drivers, and the overall market environment.
纽约2021年11月25日/美通社/--根据Technavio的数据，从2020年到2025年，体外诊断仪器市场预计将增长23亿美元。该报告对当前市场形势、最新趋势和驱动因素以及整体市场环境进行了最新分析。
Fetch Free Sample Report to explore growth opportunities in the in-vitro diagnostics instruments market
免费取样报表探索体外诊断仪器市场的增长机会
Top 3 In-vitro Diagnostics Instruments Market Players
排名前3位的体外诊断仪器市场参与者
- Abbott Laboratories- The company offers in-vitro diagnostics instruments, namely Sapphire, Ruby, Emerald 22AL, and others.
- Becton Dickinson and Co.- The company offers in-vitro diagnostics instruments for mycobacteria testing and identification and susceptibility systems.
- Bio Rad Laboratories Inc.- The company offers in-vitro diagnostics instruments to screen microbial presence, grow and identify organisms, and test for antibiotic susceptibility.
- 雅培-该公司提供体外诊断仪器，即蓝宝石、红宝石、翡翠22AL等。
- 贝顿·狄金森以及公司-该公司提供用于分枝杆菌检测、鉴定和药敏系统的体外诊断仪器。
- Bio Rad实验室公司-该公司提供体外诊断仪器，以筛选微生物的存在，培养和鉴定生物体，并测试抗生素敏感性。
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!
终身访问我们的Technavio Insight。现在就订阅我们最受欢迎的“Lite计划”每年收费3000美元。每月查看3份报告，每年下载3份报告！
In-vitro Diagnostics Instruments Market 2021-2025: Segmentation
2021-2025年体外诊断仪器市场细分
- Product
- Immunochemistry
- Clinical Microbiology
- Molecular Diagnostics
- Others
- End-user
- Hospitals And Diagnostic Laboratories
- Academic And Research Institutes
- Home Care
- Geography
- North America
- Europe
- Asia
- ROW
- 产品
- 免疫化学
- 临床微生物学
- 分子诊断学
- 其他
- 最终用户
- 医院和诊断实验室
- 学术和研究机构
- 家庭护理
- 地理学
- 北美
- 欧洲
- 亚洲
- 划
The in-vitro diagnostics instruments market is driven by the growing geriatric population, demand for personalized medicine, and product launches.
体外诊断仪器市场是由不断增长的老年人口、对个性化药物的需求以及产品发布推动的。
Download Our Free Sample for more information about market segmentation as well as the latest trends, drivers, and challenges
下载我们的免费样本有关细分市场以及最新趋势、驱动因素和挑战的更多信息
Reports that might interest you:
您可能感兴趣的报告：
- Surgical Instruments Market: The surgical instruments market has been segmented by product (surgical sutures and stapling devices, handheld surgical devices, and electrosurgical devices) and geography (North America, Asia, Europe, and ROW). Download Free Sample Report
- Ventricular Assist Devices Market: The ventricular assist devices market has been segmented by product (left and right ventricular assist devices and bi-ventricular assist devices) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
- 手术器械市场：手术器械市场已按产品(手术缝合线和吻合器、手持手术器械和电外科器械)和地理位置(北美, 亚洲, 欧洲和ROW)。下载免费样本报告
- 心室辅助设备市场：心室辅助设备市场已按产品(左、右心室辅助设备和双心室辅助设备)和地域(北美, 欧洲, 亚洲和ROW)。下载免费样本报告
|
In-vitro Diagnostics Instruments Market Scope | |
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.95% |
|
Market growth 2021-2025 |
USD 23.00 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
6.23 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 35% |
|
Key consumer countries |
US, China, Germany, Canada, and UK |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., HORIBA Ltd., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
|
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
|
体外诊断仪器的市场范围 | |
|
报告覆盖范围 |
细节 |
|
页码 |
120 |
|
基准年 |
2020 |
|
预测期 |
2021-2025 |
|
增长动能与复合年增长率 |
以7.95%的复合年均增长率加速 |
|
2021-2025年市场增长 |
23亿美元 |
|
市场结构 |
支离破碎 |
|
同比增长(%) |
6.23 |
|
区域分析 |
北美、欧洲、亚洲和ROW |
|
表演市场贡献 |
北美为35% |
|
主要消费国 |
美国、中国、德国、加拿大和英国 |
|
竞争格局 |
领先公司、竞争战略、消费者参与范围 |
|
公司概况 |
雅培、Becton Dickinson和Co.、Bio Rad实验室公司、Bio Merieux SA、Danaher Corp.、F.Hoffmann-La Roche Ltd.、HORIBA Ltd.、西门子股份公司、Sysmex Corp.和赛默飞世尔。 |
|
市场动态 |
母市场分析，市场增长诱因和障碍，快增长和慢增长细分市场分析，新冠肺炎影响和未来消费者动态，预测期市场状况分析 |
|
定制权限 |
如果我们的报告没有包括您正在寻找的数据，您可以联系我们的分析师并定制细分市场。 |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
关于我们
Technavio是一家全球领先的技术研究和咨询公司。他们的研究和分析专注于新兴市场趋势，并提供可操作的见解，帮助企业识别市场机会并制定有效的战略，以优化其市场地位。Technavio的报告库拥有500多名专业分析师，由17000多份报告组成，并在不断统计，涵盖了横跨50个国家和地区的800项技术。他们的客户群包括各种规模的企业，其中包括100多家财富500强公司。不断增长的客户基础依赖于Technavio的全面覆盖、广泛的研究和可操作的市场洞察力，以确定现有和潜在市场中的机会，并评估它们在不断变化的市场情景中的竞争地位。
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
联系人
技术研究
杰西·迈达
媒体与营销主管
美国：+1 844 364 1100
英国：+44 203 893 3200
电子邮件：[受电子邮件保护]
网址：www.Technavio.com/
SOURCE Technavio
来源技术
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧